Lingxun Duan

Migra-Therapeutics, Llc

$311,479

Attributed

$934,438

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

NIH$934,438 · 1

By mechanism

R44$934,438 · 1

Top collaborators

Lily Yang1 shared
Lei Zhu1 shared

Most similar at Migra-Therapeutics, Llc

Same institution · by research overlap

Lei Zhu$954,772

Others in their field

Other Rising Stars on “Adverse Event”

Lauren Miller · Technical Resources International, Inc.$31,120,905
Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
Cathie Snyder · Rho Federal Systems Division, Inc.$13,688,224
Jinsy Andrews · Columbia University Health Sciences$11,474,975
Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
Eric Anderson · Columbia University Health Sciences$11,474,975

Research focus

Adverse EventAwardBiochemicalBiodistributionBiological MarkersBiologyBiophysicsCancer BiologyCancer CellCancer PatientCancer SurvivalCancer TherapyCancer TypeCatalytic DomainChemotherapyClinical TranslationClinical TrialsDensityDesignDoseDrug Delivery SystemsDrug DevelopmentDrug KineticsAdvanced Pancreatic Cancer

Grant awards (1)

Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy$934,438

R44 · FY2022 · CA